Mironid is a biopharmaceutical company focused on developing treatments for rare kidney diseases, inflammatory diseases, and cancer. They aim to improve patient outcomes with innovative therapeutic solutions.
Founded
2015
Total Funding
Tens of millions
Total Rounds
3
First Raise
Jun 20, 2016
Latest Raise
Aug 8, 2026
New funding rounds in your inbox every week 路 No noise, all Signal.
Founders and leadership hierarchy for this company.
| Date | Deal Type | Amount | Lead Investor |
|---|---|---|---|
| 8/8/2026 | |||
2 more funding rounds available
Upgrade to Premium to view all historical funding rounds
Upgrade to Premium to view Capital Momentum Score and performance metrics
New funding rounds in your inbox every week 路 Free